review Open AccessTop 1% cited
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
AIDS · 2016 · Vol. 30(12) · pp. 1973–1983
Virginia A. Fonner✉(Medical University of South Carolina)Sarah L DalglishCaitlin E. KennedyRachel BaggaleyKevin O’ReillyFlorence KoechlinMichelle RodolphIoannis Hodges-MameletzisRobert M. Grant
Abstract
PrEP is protective against HIV infection across populations, presents few significant safety risks, and there is no evidence of behavioral risk compensation. The effective and cost-effective use of PrEP will require development of best practices for fostering uptake and adherence among people at substantial HIV risk.
HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskAdolescent Sexual and Reproductive HealthPre-exposure prophylaxisMedicineAdverse effectMeta-analysisPlaceboRisk compensationRelative riskConfidence intervalInternal medicineHuman immunodeficiency virus (HIV)
MeSH terms
TenofovirAdministration, OralAdultFemaleHumansMalePlacebosHIV InfectionsChemopreventionAnti-HIV AgentsYoung AdultPre-Exposure Prophylaxis
Funding
- Bill and Melinda Gates Foundation
Citations
1,008
FWCI
66.02
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Cited by
Mental health and HIV/AIDS
AIDS · 2019 · 701 citations
References
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
The Lancet Infectious Diseases · 2014 · 1,239 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
PLoS Medicine · 2009 · 63,014 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.